We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+2.77%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11.3B
AUM Growth
-$128M
Cap. Flow
-$697M
Cap. Flow %
-6.16%
Top 10 Hldgs %
41.41%
Holding
1,243
New
52
Increased
320
Reduced
317
Closed
40

Top Buys

Rank Stock Value
1
HST icon
Host Hotels & Resorts
HST
+$98.9M
2
PSA icon
Public Storage
PSA
+$78.4M
3
MAC icon
Macerich
MAC
+$57.8M
4
VICI icon
VICI Properties
VICI
+$56M
5
EQR icon
Equity Residential
EQR
+$46.3M

Top Sells

Rank Stock Value
1
DLR icon
Digital Realty Trust
DLR
+$144M
2
AMT icon
American Tower
AMT
+$112M
3
LSI
Life Storage, Inc.
LSI
+$105M
4
CUZ icon
Cousins Properties
CUZ
+$69.4M
5
DOC icon
Healthpeak Properties
DOC
+$67.5M

Sector Composition

Rank Sector Weight
1 Real Estate 72.31%
2 Technology 4.13%
3 Industrials 3.02%
4 Financials 2.93%
5 Healthcare 2.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EPZM
1051
DELISTED
Epizyme, Inc
EPZM
$7K ﹤0.01%
571
+67
+13% +$862
EIDX
1052
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$7K ﹤0.01%
234
– –
AMPH icon
1053
Amphastar Pharmaceuticals
AMPH
$825M
$6K ﹤0.01%
296
+42
+17% +$878
ANIP icon
1054
ANI Pharmaceuticals
ANIP
$1.77B
$6K ﹤0.01%
76
+12
+19% +$853
ATRA icon
1055
Atara Biotherapeutics
ATRA
$71.2M
$6K ﹤0.01%
12
– –
FL
1056
DELISTED
Foot Locker
FL
$6K ﹤0.01%
152
– –
PACB icon
1057
Pacific Biosciences
PACB
$422M
$6K ﹤0.01%
960
– –
TBPH icon
1058
Theravance Biopharma
TBPH
$874M
$6K ﹤0.01%
353
– –
VYGR icon
1059
Voyager Therapeutics
VYGR
$187M
$6K ﹤0.01%
232
+54
+30% +$1.24K
WVE icon
1060
Wave Life Sciences
WVE
$1.12B
$6K ﹤0.01%
213
– –
NSTG
1061
DELISTED
NanoString Technologies, Inc.
NSTG
$6K ﹤0.01%
196
– –
SPPI
1062
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$6K ﹤0.01%
706
– –
ENDP
1063
DELISTED
Endo International plc
ENDP
$6K ﹤0.01%
1,427
– –
DRNA
1064
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$6K ﹤0.01%
399
– –
LMNX
1065
DELISTED
Luminex Corp
LMNX
$6K ﹤0.01%
284
– –
VER
1066
CALL
DELISTED
VEREIT, Inc.
VER
$6K ﹤0.01%
261
– –
AMAG
1067
PUT
DELISTED
AMAG Pharmaceuticals
AMAG
$6K ﹤0.01%
+229
New +$2.47K
ALDR
1068
DELISTED
Alder Biopharmaceuticals
ALDR
$6K ﹤0.01%
508
– –
ADVM
1069
DELISTED
Adverum Biotechnologies
ADVM
$5K ﹤0.01%
41
– –
CERS icon
1070
Cerus
CERS
$587M
$5K ﹤0.01%
871
– –
HCM icon
1071
HUTCHMED
HCM
$1.89B
$5K ﹤0.01%
215
– –
KURA icon
1072
Kura Oncology
KURA
$922M
$5K ﹤0.01%
242
– –
MGNX icon
1073
MacroGenics
MGNX
$235M
$5K ﹤0.01%
310
– –
NTLA icon
1074
Intellia Therapeutics
NTLA
$1.5B
$5K ﹤0.01%
288
+54
+23% +$849
OMER icon
1075
Omeros
OMER
$709M
$5K ﹤0.01%
309
+44
+17% +$790
41 42
43
44 45

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2019 Portfolio in Review

As of Q2 2019, Daiwa Securities Group held 1,243 positions worth $11.3B, down 1.1% from $11.4B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Daiwa Securities Group withdrew a net $697M in Q2 2019, closing 40 positions and reducing 317 holdings. Its most notable exit was L3Harris, an estimated $3.77M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 72% of assets, down from 74% a quarter earlier, followed by Technology and Industrials.

Against the trend, Daiwa Securities Group opened a new position in Coupa Software Incorporated worth $4.17M.

  • Daiwa Securities Group's largest Q2 2019 buy was Coupa Software Incorporated: 32,900 shares worth $4.17M.
  • Daiwa Securities Group added most to Host Hotels & Resorts in Q2 2019, an estimated $98.9M increase.
  • Daiwa Securities Group's biggest Q2 2019 reduction was Digital Realty Trust, cutting an estimated $144M.
  • Daiwa Securities Group fully exited L3Harris in Q2 2019, selling an estimated $3.77M.
  • Daiwa Securities Group's ten largest holdings make up 41% of its $11.3B portfolio in Q2 2019.
  • Daiwa Securities Group opened 52 new positions and closed 40 in Q2 2019.
  • Daiwa Securities Group's portfolio value fell 1.1% quarter-over-quarter to $11.3B.

Based on Daiwa Securities Group's 13F filing for Q2 2019, filed 24 Jul 2019.